ARTICLE | Company News
Prelude, Rosetta Genomics deal
May 4, 2015 7:00 AM UTC
Rosetta Genomics acquired fellow molecular diagnostics and services company PersonalizeDx from Prelude for $2 million in cash and 500,000 Rosetta shares valued at $1.5 million based on Rosetta’s close...